128 related articles for article (PubMed ID: 23728096)
1. [Sustained-release progesterone vaginal suppositories 3-development and clinical feasibility testing].
Nakayama A; Yamaguchi N; Ohno Y; Miyata C; Kondo H; Sunada H; Okamoto H
Yakugaku Zasshi; 2013; 133(6):727-36. PubMed ID: 23728096
[TBL] [Abstract][Full Text] [Related]
2. [Sustained release double-layered progesterone suppository for luteal support therapy].
Iwata M; Takahashi Y; Shirotake S; Yamamoto T; Takayama K; Machida Y; Hirahara F; Minaguchi K; Nagai T
Yakugaku Zasshi; 1997 Sep; 117(9):629-35. PubMed ID: 9357331
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release progesterone vaginal suppositories 1--development of sustained-release granule--.
Nakayama A; Sunada H; Okamoto H; Furuhashi K; Ohno Y; Ito M
Biol Pharm Bull; 2009 Feb; 32(2):276-82. PubMed ID: 19182389
[TBL] [Abstract][Full Text] [Related]
4. Serum progesterone levels following vaginal administration of progesterone during the luteal phase.
Myers ER; Sondheimer SJ; Freeman EW; Strauss JF; Rickels K
Fertil Steril; 1987 Jan; 47(1):71-5. PubMed ID: 3792576
[TBL] [Abstract][Full Text] [Related]
5. Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma.
Shiohira H; Fujii M; Koizumi N; Kondoh M; Watanabe Y
Int J Pharm; 2009 Sep; 379(1):119-24. PubMed ID: 19555748
[TBL] [Abstract][Full Text] [Related]
6. Quality of Progesterone Suppositories Prepared by FIRST-Progesterone Vaginal Suppository 50 Kit or Traditional Compounding Method: In Vitro Comparison.
Chauhan H; Atef E
Int J Pharm Compd; 2009; 13(4):342-4. PubMed ID: 23966524
[TBL] [Abstract][Full Text] [Related]
7. 3D printing of unique water-soluble polymer-based suppository shell for controlled drug release.
Tagami T; Hayashi N; Sakai N; Ozeki T
Int J Pharm; 2019 Sep; 568():118494. PubMed ID: 31276763
[TBL] [Abstract][Full Text] [Related]
8. Comparison of serum progesterone levels in dogs after administration of progesterone by vaginal tablet and vaginal suppositories.
Fulper LD; Cleary RW; Harland EC; Hikal AH; Jones AB
Am J Obstet Gynecol; 1987 Jan; 156(1):253-6. PubMed ID: 3799758
[TBL] [Abstract][Full Text] [Related]
9. [Study of Preparation and Utility of Suppository Containing Carbamazepine Tablet for Hospital Use in Rabbits].
Murata I; Arai N; Fukushima A; Saito A; Inoue Y; Kimura M; Kanamoto I
Yakugaku Zasshi; 2015; 135(9):1049-55. PubMed ID: 26329551
[TBL] [Abstract][Full Text] [Related]
10. Can we alter pregnancy outcome by adjusting progesterone treatment at mid-luteal phase: a randomized controlled trial.
Aslih N; Ellenbogen A; Shavit T; Michaeli M; Yakobi D; Shalom-Paz E
Gynecol Endocrinol; 2017 Aug; 33(8):602-606. PubMed ID: 28277886
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence of progesterone sustained release suppository in rabbits.
Long L; Huang Q; Wu M; Hou S; Dai Z
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(4):470-2. PubMed ID: 16196307
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of morphine in rabbits after rectal administration of suppository containing controlled release morphine tablet.
Kanamoto I; Zheng NX; Ueno M; Koizumi T; Adachi I; Horikoshi I
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1883-6. PubMed ID: 1394709
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1680-3. PubMed ID: 2208382
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of natural progesterone vaginal suppository.
von Eye Corleta H; Capp E; Ferreira MB
Gynecol Obstet Invest; 2004; 58(2):105-8. PubMed ID: 15192285
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin sustained-release suppositories containing sugar ester.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):1027-31. PubMed ID: 2379274
[TBL] [Abstract][Full Text] [Related]
16. Effect of the suppository base on progesterone delivery from the vagina.
Price JH; Ismail H; Gorwill RH; Sarda IR
Fertil Steril; 1983 Apr; 39(4):490-3. PubMed ID: 6832405
[TBL] [Abstract][Full Text] [Related]
17. Progesterone support for frozen embryo transfer: intramuscular versus vaginal suppository demonstrates no difference in a cohort.
Leonard PH; Hokenstad AN; Khan Z; Jensen JR; Stewart EA; Coddington CC
J Reprod Med; 2015; 60(3-4):103-8. PubMed ID: 25898472
[TBL] [Abstract][Full Text] [Related]
18. [Controlled release of prednisolone from suppository prepared using powder of pulverized tablet].
Tatsumi A; Oda S; Nakamoto T; Muraoka R; Takahashi Y; Tanaka K; Shikata T; Tatsumi S; Tagawa N; Kobayashi Y; Hamaguchi T; Kadobayashi M
Yakugaku Zasshi; 2008 Apr; 128(4):641-8. PubMed ID: 18379182
[TBL] [Abstract][Full Text] [Related]
19. Release property of progesterone from a mixed-base suppository consisting of Witepsol W35 and Witepsol E85.
Iwata M; Komiya S; Nakamura K; Kiuchi M; Andoh N; Hirahara F; Maitani Y; Takayama K
Drug Dev Ind Pharm; 2001 Nov; 27(10):1039-45. PubMed ID: 11794806
[TBL] [Abstract][Full Text] [Related]
20. Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel.
Mahaguna V; McDermott JM; Zhang F; Ochoa F
Drug Dev Ind Pharm; 2004; 30(10):1069-78. PubMed ID: 15595573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
